Navigation Links
Clearview Treatment Programs to Hold Workshop on Evidence-Based Treatment for Dual Diagnoses
Date:6/4/2013

Venice Beach, Calif. (PRWEB) June 04, 2013

On Friday, June 14, 2013, Clearview Treatment Programs will present “Integrative Treatment for Dual Diagnoses: Evidence-Based Treatments That Work,” in Venice Beach, Calif.

The clinical workshop will provide participants practical knowledge of Motivational Interviewing, Acceptance and Commitment Therapy (ACT), and Cognitive Behavioral Therapy (CBT):

  • Motivational Interviewing is a goal-oriented form of treatment that is designed to help with ambivalence, motivation, and change, and can be highly effective in dual diagnosis treatment. Motivational Interviewing includes a series of four stages: pre-contemplative, contemplative, preparation and action, followed by the maintenance stage.
  • Acceptance and Commitment Therapy (ACT) is a therapy that uses mindfulness and acceptance strategies to build psychological flexibility. One of the core tenets of ACT is accepting one’s painful emotions, and to develop a new set of values to help overcome the negativity they experience in life. ACT is very effective with clients who suffer from addictions and dual diagnosis.
  • Cognitive Behavioral Therapy (CBT) helps clients address their dysfunctional thinking and behavior that perpetuate problems with mental health and substance abuse disorders. It examines problematic symptoms that are persistent because the clients need skills to challenge their underlying irrational thinking about how they view themselves, others, and the world.

“These evidence-based treatments have proven to be extremely effective when it comes to treating dual diagnosis,” said Michael Roy, LCSW, MSW, executive director of Clearview Treatment Programs, a premier dual diagnosis treatment center in Los Angeles. “This workshop provides a concise overview of how they can work for therapists who treat that population.”

Featured speakers at the workshop will be Chelsea Cawood, Ph.D., therapist at Clearview Women’s Center for Borderline Personality Disorder; Matt Swank, MSW, LCSW, therapist at Clearview Center for Psychiatric Disorders and Addictions; and Nicole Zaha, Psy.D., therapist at Clearview Women’s Center.

The workshop will be held from 8:30 a.m. to 12:30 p.m. at Clearview Center in Venice Beach. Admission to the workshop is $35, which includes a light breakfast. The clinical workshop is offering 3.5 continuing education units for MFTs and LCSWs.

Register here for this clinical workshop.

About Clearview Treatment Programs

Clearview Treatment Programs in Venice Beach, Calif., is a premier provider of mental health and addiction treatment. Clearview provides highly individualized treatment programs for people with psychiatric disorders, alcohol and drug addictions, and dual diagnosis.

Clearview Treatment Programs, started in 2000, operates multiple treatment centers in the Southern California beach communities and the Los Angeles area. Clearview offers a full continuum of care, including residential treatment, day treatment, outpatient treatment, and transitional living treatment centers in Los Angeles.

For more information, please visit http://www.clearviewtreatment.com.

About Clearview Women’s Center

Clearview Women's Center for Borderline Personality and Emotional Disorders offers residential, day treatment, and outpatient comprehensive Dialectical Behavior Therapy (DBT) programs. Our programs are designed to treat women who struggle with emotional dysregulation, relational conflicts, impulse control, and/or self-harmful behaviors.

For more information, please visit our website http://www.clearviewwomenscenter.com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10796646.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DBT Expert Charles Swenson to Present at Upcoming Clearview Workshop
2. Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD
3. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
4. Clinical insight improves treatment with new lung cancer drug
5. Rapid Asthma Treatment in ER May Prevent Admission
6. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
7. Breast cancer patients suffer treatment-related side effects long after completing care
8. Mayo Clinic offers newly approved treatment for acid reflux disease
9. Mobile Stroke Units Might Trim Time to Treatment
10. Breast Cancer Treatment Side Effects May Last for Years
11. Mouse Study Hints at New Path for Diabetes Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: